Pediatric Allergy
Testing confirms very few parent-reported pediatric drug allergies
Although 7% of questioned parents believed that their child had a drug allergy, testing showed that only 0.05% of these children had a true drug allergy, according to a study published in Annals of Allergy, Asthma & Immunology.
Novel therapy reduces food allergy anxiety among children
Anxiety related to food allergy among children goes beyond being nervous in uncontrolled environments where triggers may be encountered, and current therapies may fall short of addressing the specific needs of these patients.
Q&A: Food allergy conference brings families, experts together
Families with food allergies as well as nutritionists, dietitians and other stakeholder professionals can connect with expert clinicians and researchers at Food Allergy Summit 2022, scheduled for Sept. 23 to 25 in Orlando.
Q&A: Inaugural North American conference to focus on pediatric food allergy
As pediatric allergy rates increase and therapy progresses, experts will address these issues at the inaugural North American Pediatric Allergy & Asthma Congress, Sept. 21 to 22, in Quebec City.
Q&A: Missouri legislation allows trained school personnel to administer epinephrine
Gov. Mike Parson of Missouri has signed SB 710, which authorizes all school personnel in the state trained by a nurse to administer epinephrine via autoinjector to any student experiencing anaphylaxis without any civil liability.
Meet the Board: Jennifer A. Dantzer, MD, MHS
Jennifer A. Dantzer, MD, MHS, is focused on improving the lives of children with allergy.
Q&A: Sublingual immunotherapy viable for treating respiratory allergy in children
Sublingual immunotherapy does more than relieve symptoms of respiratory allergy in children. It also modifies the disease, according to a review published in Allergy and Asthma Proceedings as part of its Allergen Immunotherapy (AIT) Primer.
Real-world data show oral immunotherapy for peanut allergy is safe, effective in infants
In a real-world setting, peanut oral immunotherapy was safer in infants aged 12 months or younger than in children aged 1 to 5 years, according to recent data.
Oral immunotherapy may lead to remission of peanut allergy in young children
Oral immunotherapy was associated with an increase in both desensitization and remission of peanut allergy among children aged younger than 4 years, with younger children seeing greater success, according to data published in The Lancet.
Sesame allergy often resolves in patients with mild reactions at young ages
Researchers found that sesame allergy spontaneously resolved in approximately one-third of patients who had a mild first reaction at a young age, according to a study published in Annals of Allergy, Asthma & Immunology.